Please login to the form below

Research Pipeline

This page shows the latest Research Pipeline news and features for those working in and with pharma, biotech and healthcare.

CRUK forges £30m ‘post-Brexit’ R&D alliance

No single organisation or country is going to beat cancer on its own,” commented Dr Iain Foulkes, executive director of research and innovation at CRUK. ... Our Accelerator Award funding will lay the groundwork for a Europe and UK research pipeline,

Latest news

GSK: we won’t be splitting up any time soon

The company has 27 immunomodulatory new molecular entities (NME) in clinical trials, around 60% of its total clinical pipeline. ... GSK is investing $300m in the firm, and says a long-term partnership to exploit its genetic databases will help it advance
Daily Brief: GSK unveils R&D plan, Keytruda OK'd for lymphoma by NICE

News from pharma, biotech and healthcare. 23andMe alliance part of GSK’s new research plan. ... GSK’s CEO Emma Walmsley (pictured) has restated her determination to revive the firm’s research pipeline in a statement this morning, ahead of an
Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO

Novartis already has ZPL389 in its pipeline, a phase II ezcema treatment it gained with the acquisition of Ziarco two years ago. ... The company, based in London and New York, has four ongoing clinical programmes, one compassionate use programme and a
BenevolentAI claims AI first with new Cambridge facility

Says its new drug discovery and development base will cover the entire research process. ... The company has previously generated novel drug candidates to treat a range of complex and previously untreatable diseases and within the last two year has built
Artificial intelligence firm licenses Janssen candidates for development

Janssen has licensed a number of pipeline candidates to a UK artificial intelligence company that wants to use technology to innovate the drug development process. ... The London-based firm said the agreement would enable it to accelerate its development

More from news
Approximately 3 fully matching, plus 41 partially matching documents found.

Latest Intelligence

Heart failure therapy embarks on a new era

There are also a number of other drugs coming through the research pipelines. ... Pipeline growing. While Entresto and ivabradine promise to make a significant impact in HF, there are also a number of other investigational drugs coming through the
Eisai: Bucking the trend with R&D growth

Research pipeline. Research at Eisai is focused on three key areas: neuroscience, oncology and vascular/immunological diseases. . ... Commercial expansion. But it's not just in research spending that Eisai is bucking industry trends.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

Sigma-Tau Pharmaceuticals appoints CEO

a time of development in the company, as it expands through registration, life-cycle management and commercialisation of its proprietary research and development pipeline.
Adaptimmune appoints former GSK executives

He will also lead the development of the company's pipeline of research programmes.
MedDay appoints former Sanofi VP to board

MedDay, which was only formed in 2011, will welcome Goupit's knowledge of business development as it looks to expand with its pipeline of drugs for nervous system disorders such as ... Goupit said: “I strongly believe that MedDay's product pipeline and
Galapagos appoints Bart Filius as chief financial officer

As we move forward and the pipeline matures further, I look forward to bringing my experience in finance and M&A to Galapagos.”. ... pipeline company” to a research-focused biotech firm.